Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 28,935 shares at $20.06 ($581K) on 2026-06-25, disclosed to the SEC on 2026-06-25.
Scheduled sale ($581k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |